Company news
Allergy Therapeutics plc news in 2025
Allergy Therapeutics plc's news releases, calls and decks from 2025, newest first.
Results of General Meeting
December 29, 2025
Grassmuno® marketing authorisation in Germany
December 16, 2025
Authority for allotment of New Shares
December 12, 2025
Prelim Results and publication of Annual Report
December 11, 2025
Primary Safety Endpoint Met in PROTECT trial
December 9, 2025
Company to Evaluate Dual Listing on HKEX
November 6, 2025
G308 Phase III Year 2 Patient Screening Starts
October 30, 2025
Warrant Exercise and Paydown of Debt
October 29, 2025
Further progress in Phase I/IIa PROTECT trial
October 16, 2025
Grass MATA MPL Publications in Allergy Journal
July 31, 2025
Trading update for the year ended 30 June 2025
July 21, 2025
PDMR Dealings
July 11, 2025
Allergy Therapeutics presents findings at EAACI
June 13, 2025
EAACI Early Career Research Award
June 10, 2025
Interim Results for six months ended 31 Dec 2024
March 31, 2025
Advancement to final phase of PROTECT trial
March 27, 2025
New Executive Long Term Incentive Awards
March 3, 2025
Presentations at 2025 AAAAI / WAO Joint Congress
February 27, 2025
Grass MATA MPL Phase III data published in Allergy
February 17, 2025
Grant of Options
February 14, 2025
Half Year Trading update
January 28, 2025
PDMR Dealing and Total Voting Rights
January 22, 2025
Director/PDMR Shareholding
January 15, 2025